Related content

Secondary prevention of osteoporotic fractures—an “OPTIMAL” model of care from Singapore

By Chandran M.   Tan M.   Cheen M.   Tan S.   Leong M.   Lau T.  

Osteoporosis International, Vol. 24, Iss. 11, 2013-11 ,pp. : 2809-2817

Springer Publishing Company

Access to resources Recommend Favorite

Long-term use of bisphosphonates in osteoporosis

By Rizzoli René  

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 309-315

Future Medicine

Access to resources Recommend Favorite

Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women

By Rabenda V.   Mertens R.   Fabri V.   Vanoverloop J.   Sumkay F.   Vannecke C.   Deswaef A.   Verpooten G.   Reginster J.-Y.  

Osteoporosis International, Vol. 19, Iss. 6, 2008-06 ,pp. : 811-818

Springer Publishing Company

Access to resources Recommend Favorite

Is Long‐Term Anti‐Osteoporotic Treatment Associated with Greater Risk of Cancer in People with Severe Vertebral Fractures? A Hospital‐Based Cohort Study

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 11, 2015-11 ,pp. : 2418-2419

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

By Rizzoli R.   Åkesson K.   Bouxsein M.   Kanis J.   Napoli N.   Papapoulos S.   Reginster J.-Y.   Cooper C.  

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 373-390

Springer Publishing Company

Access to resources Recommend Favorite